Department of Ophthalmology, Duke University, Durham, North Carolina, U.S.A.
Ophthalmic Plast Reconstr Surg. 2021;37(1):42-50. doi: 10.1097/IOP.0000000000001676.
To assess early outcomes of corneal neurotization for postherpetic neurotrophic keratopathy (NK).
Retrospective analysis of patients who underwent corneal neurotization for postherpetic NK by a single experienced oculoplastic surgeon was performed. Collected data included stage and etiology of NK as well as comorbidities, prior treatment history, neurotization technique, donor nerve site, preoperative and postoperative examination findings (i.e., ocular surface quality, corneal clarity, corneal sensation by Cochet-Bonnet esthesiometry, and visual acuity [VA]), and follow-up duration. Differences between preoperative and postoperative values were analyzed by Wilcoxon signed-rank test.
Of 23 adult patients who underwent corneal neurotization, 3 (13%) had history of herpes simplex keratitis and/or endotheliitis, and 4 (17%) had history of herpes zoster ophthalmicus. One patient with herpes zoster ophthalmicus was excluded due to inadequate follow-up duration. Of the 6 patients included in the study, 3 (50%) had Mackie stage 1 disease, 1 (17%) had stage 2, and 2 (33%) had stage 3 with impending perforation, but all had markedly diminished corneal sensation, with a median denervation time of 11.8 months (interquartile range [IQR] 9.4-29.2 months). Following neurotization, median corneal sensation improved significantly from 1.6 cm (interquartile range 0.0-1.9 cm) to 3.6 cm (IQR 3.0-5.6 cm, p = 0.028), with 1 patient achieving full sensation by postoperative month 5. All patients with a persistent epithelial defect preoperatively showed complete corneal healing by their last follow-up visit. VA also improved postoperatively in all patients (p = 0.028). Median follow-up duration was 11.3 months (interquartile range 9.6-17.9 months).
Corneal neurotization can successfully reinnervate corneas previously devitalized by herpetic disease and halt the progressive nature of postherpetic NK. If utilized appropriately and early in the disease process, neurotization may reduce morbidity and maximize visual potential in postherpetic NK.
评估用于治疗疱疹后神经营养性角膜病变(NK)的角膜神经再支配的早期结果。
对一位经验丰富的眼整形医生为疱疹后 NK 进行角膜神经再支配的患者进行回顾性分析。收集的数据包括 NK 的阶段和病因以及合并症、既往治疗史、神经再支配技术、供体神经部位、术前和术后检查结果(即眼表质量、角膜清晰度、Cochet-Bonnet 触诊仪评估的角膜感觉和视力[VA])以及随访时间。通过 Wilcoxon 符号秩检验分析术前和术后值之间的差异。
在接受角膜神经再支配的 23 名成年患者中,有 3 名(13%)有单纯疱疹性角膜炎和/或内皮层炎病史,4 名(17%)有带状疱疹性眼病病史。由于随访时间不足,1 名带状疱疹性眼病患者被排除在外。在纳入研究的 6 名患者中,3 名(50%)为 Mackie 1 期疾病,1 名(17%)为 2 期,2 名(33%)为 3 期伴即将穿孔,但所有患者均有明显的角膜感觉减退,中位去神经支配时间为 11.8 个月(四分位距[IQR]9.4-29.2 个月)。神经再支配后,中位角膜感觉从 1.6cm(IQR0.0-1.9cm)显著改善至 3.6cm(IQR3.0-5.6cm,p=0.028),1 名患者在术后第 5 个月时达到完全感觉。所有术前存在持续性上皮缺损的患者在末次随访时均完全愈合角膜。所有患者的视力在术后均改善(p=0.028)。中位随访时间为 11.3 个月(IQR9.6-17.9 个月)。
角膜神经再支配可以成功地重新支配以前因疱疹性疾病而失活的角膜,并阻止疱疹后 NK 的进行性发展。如果在疾病过程中尽早适当使用神经再支配,它可能会减少疱疹后 NK 的发病率并最大限度地提高视力潜力。